Stay updated on FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial

Sign up to get notified when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the Phase 2 FG-3019 study in people with liver fibrosis due to chronic hepatitis B is now displayed, including study design and participant details. The record states that the trial was terminated because of an unexpected prominent effect of entecavir alone in this patient population.
    Difference
    44%
    Check dated 2026-11-08T09:55:53.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-11-01T11:21:58.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T11:44:41.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label updates from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:38:46.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:52:03.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating access is blocked. As a result, the study details and navigation are no longer visible on the page.
    Difference
    17%
    Check dated 2026-09-20T20:09:50.000Z thumbnail image

Stay in the know with updates to FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.